The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of atezolizumab and bevacizumab with or without transarterial chemoembolization as first-line therapy for advanced hepatocellular carcinoma: An international multicenter real-world study.
 
Ningning Zhang
No Relationships to Disclose
 
Kaipeng Liu
No Relationships to Disclose
 
Yuexi Yu
No Relationships to Disclose
 
Kai Yuan
No Relationships to Disclose
 
Haipeng Yu
No Relationships to Disclose
 
Jean-Charles Nault
Research Funding - Bayer (Inst); Ipsen (Inst)
Patents, Royalties, Other Intellectual Property - New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene Therapy
 
Claudia Campani
No Relationships to Disclose
 
Lorraine Blaise
No Relationships to Disclose
 
Sarah Mouri
No Relationships to Disclose
 
Eleonore Spitzer
No Relationships to Disclose
 
Yawei Du
No Relationships to Disclose
 
Shuwen Zhang
No Relationships to Disclose
 
Wenwen Zhu
No Relationships to Disclose
 
Hao Yu
No Relationships to Disclose
 
Xuanchen Liu
No Relationships to Disclose
 
Ming Luo
No Relationships to Disclose
 
Duan Feng
No Relationships to Disclose
 
Manon Allaire
No Relationships to Disclose
 
Wei Lu
No Relationships to Disclose
 
Jihui Hao
No Relationships to Disclose